ESWT on Human Gingival Fibroblasts

Status Completed

Clinical Trial Summary

The idea of treating different deformities or diseases in the maxillofacial region with Extracorporeal Shockwave Therapy (ESWT) has recently become popular. Shockwave therapy was first introduced in Germany in 1980s and has been widely used in medical practice for the management of urolithiasis, cholelithiasis and in head and neck region for sialolithiasis. The present study 'Application of Extracorporeal Shock Wave Therapy on human gingival derived fibroblasts In-vitro study' was done to explore and evaluate the effect of shockwaves. Further, these cells were assessed for Cell - Cell interaction and Cell Viability. In this in-vitro study, 20 fibroblast cells were included. 10 samples were considered for Control group and the remaining 10 samples were considered as Test group. Extracorporeal shockwave was applied to the Test samples. They were further analysed

Clinical Trial Description

BACKGROUND: Improved understanding of human biology at the molecular level, scientific and technologic advances are emerging aspects in dentistry. The idea of treating different deformities or diseases in the maxillofacial region with Extracorporeal Shockwave Therapy (ESWT) has recently become popular. Shockwave therapy was first introduced in Germany in 1980s and has been widely used in medical practice for the management of urolithiasis, cholelithiasis and in head and neck region for sialolithiasis. AIM: The present study 'Application of Extracorporeal Shock Wave Therapy on human gingival tissue derived fibroblasts In-vitro study' was done to explore and evaluate the effect of shockwaves. Further, fibroblast cells were assessed for Cell - Cell interaction and Cell Viability. MATERIALS AND METHODS: In this in-vitro study, 20 fibroblast cells were included. 10 samples were considered for Control group and the remaining 10 samples were considered as Test group. Extracorporeal shockwave was applied to the Test samples. They were further analysed using wound scratch assay which was used to assess Cell proliferative rate and scratch closure through live imaging. MTT assay and ATP assay was used to determine Cell viability after exposure to shockwaves. ;

Study Design

Related Conditions & MeSH terms

Periodontal Attachment Loss

Clinical Trial Details

NCT number	NCT05766293
Study type	Interventional
Source	Krishnadevaraya College of Dental Sciences & Hospital
Contact
Status	Completed
Phase	N/A
Start date	August 22, 2022
Completion date	January 10, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04712630` - Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft	N/A
Completed	`NCT00632957` - Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses	N/A
Completed	`NCT04813302` - Influence of Anatomical Factors Upon Root Coverage	N/A
Completed	`NCT05631600` - Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study	Phase 2/Phase 3
Recruiting	`NCT06123000` - Modified Widman Flap vs Fibre Retention Osseous Resective Surgery	N/A
Completed	`NCT03715374` - Platelet-Rich Fibrin and Anorganic Bovine Bone vs Collagen Membrane and Anorganic Bovine Bone in Intrabony Defects	N/A
Not yet recruiting	`NCT03909568` - Bone Height and Extractions Study	N/A
Completed	`NCT03027050` - T-PRF Provides Advantages on Periodontal Healing: A Split Mouth Clinical Study	N/A
Active, not recruiting	`NCT06049589` - Therapeutic Application of Coconut Oil in Oral Health	N/A
Not yet recruiting	`NCT05858411` - Efficacy of rhPDGF as an Adjunct to Non-surgical Periodontal Therapy of Intrabony Defects	N/A
Completed	`NCT06404190` - Diode Laser Photo Activation for Pocket Reduction Decontamination A Clinical Study	Phase 1
Not yet recruiting	`NCT06309719` - Hyaluronic Acid and Polynucleotides for Supra-bony Defects	N/A
Completed	`NCT04082949` - Autologous Fibrin Glue Application as an Adjunct to Nonsurgical Periodontal Treatment of Chronic Periodontitis	Early Phase 1
Completed	`NCT02666573` - Photodynamic Therapy During Supportive Periodontal Therapy	Phase 4
Recruiting	`NCT03098498` - Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy	N/A
Completed	`NCT04802473` - Flap Thickness Upon Root Coverage With the Use of Acellular Dermal Matrix	N/A
Active, not recruiting	`NCT03510780` - Platelet-rich Fibrin and Autogenous Bone vs Enamel Matrix Derivative and Autogenous Bone in Intrabony Defects	N/A
Enrolling by invitation	`NCT05932017` - Comparison of Gingival Flap Procedure Using Conventional Surgical Loupes vs. Videoscope for Visualization
Not yet recruiting	`NCT05435378` - Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis	Early Phase 1
Completed	`NCT05816941` - Antimicrobial Photodynamic Therapy in Patients With Periodontal Disease and Type 2 Diabetes Mellitus	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

ESWT on Human Gingival Fibroblasts — ESWT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms